Latest Conference Articles

The Hematology/Oncology Pharmacy Association (HOPA) created committees, inclusion statements, and diversity, equity, and inclusion (DEI) checkpoints to improve healthcare for underserved or historically less included populations.

Before tapering patients treated for cancer off of opioids, care providers should first establish what the goals of tapering are.

Certain populations have been found to have differing prognoses, such as African American patients, who have an earlier onset of disease with a higher likelihood of an aggressive tumor type and shorter survival.

Experts note that pharmacists are well positioned to play a key role in precision oncology and molecular tumor boards.

Legal expert breaks down the history of power between federal v. state law and why Dobbs v. Jackson has caused such a stir for the pharmaceutical community.

Historically, there are many hard-to-treat mutations of non-small cell lung cancer.

President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.

Follow Pharmacy Times®’ live coverage of the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in Phoenix, Arizona from March 29 to April 1, 2023.

Improvements in progression-free survival were seen in patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.

Removing the word ‘risk’ from discussions of HIV PrEP and focusing more on environment and empowerment concerns are beneficial in this patient population.

There has not yet been established a consensus on the set of factors to use for assessing social determinants of health in practice.

Any living person with HIV should be screened for hepatitis B and C upon diagnosis, with annual screenings recommended for those with additional risk factors.

Dobbs v. Jackson muddied the waters for pharmacists in strict abortion states, who must make decisions despite misaligned state and federal laws.

Expert discusses how patients who participate in Ramadan, a month of fasting in Islam, can stay safe while doing it, and offers insight into how patients can work with pharmacists to adapt to their medication needs.

Currently, APHA has a policy on its books that opposes both drug legalization and decriminalization.

The pandemic was eye-opening for many pharmacists, and one expert reflects on recognizing the importance of the pharmacy technician and accessible healthcare.

Key lifestyle risk factors for chronic diseases and cancers include tobacco use, poor nutrition, lack of physical movement, and obesity.

Akram Hussein, PharmD, MBA, BCNP, discusses the treatment process when treating a patient with prostate cancer with a radiopharmaceutical.

More and more data, both from real world analyses and clinical trials, are shedding light on the effective uses of cannabis, as well as the contraindications for its use in patients.

Even the terms themselves, “sex” and “gender,” are often misused and misunderstood by US society and medical professionals alike.

An expert suggests that education and agency are significant barriers to care in marginalized communities, which she discusses live with Pharmacy Times at the American Pharmacists Association (APhA) Meeting & Exposition in Phoenix, Arizona from March 24 to 27.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, discusses some of the ways that social determinants of health can impact patient health outcomes.

Expert weighs the benefits and pitfalls of social media, the importance of quality information from credible journal sources, and why information that sparks an emotional response can be more influential than evidence-based facts.

Although attention-deficit/hyperactivity disorder (ADHD) is not as common in adults, it can still be present and bothersome, however, adults with ADHD may have learned to hide it a bit better than children.

Prior to the pandemic, the seasonality of respiratory syncytial virus followed a pattern; now, this pattern of disease spread has changed significantly.

Vibhuti Arya, PharmD, MPH, FAPhA, explains how APhA as an organization is opening discourse among its members regarding unpacking and dismantling structural racism in the organization and in the profession at large.

Vibhuti Arya, PharmD, MPH, FAPhA, discusses the role of the individual in progressing structural and systemic changes in the pharmacy ecosystem.

Specifically, non-opioids are often preferred for the management of subacute and chronic pain because of their safety profiles.

Although community oncology has grown, maintaining services for patients is an ongoing challenge.

Presenter at the 2023 Community Oncology Alliance meeting notes that oncology has become more of a duality between molecular and genetic subsets, leading to huge developments in targeted and personalized care.